| 1 |
Torres PA, De Broe M. Calcium-sensing receptor, calcimimetics,and cardiovascular calcifications in chronic kidney disease [J].Kidney Int, 2012, 82(1): 19-25.
|
| 2 |
Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease [J]. Circulation. 2008, 117(22): 2938-2948.
|
| 3 |
Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J]. Am J Kidney Dis, 2008, 52(3): 519-530.
|
| 4 |
Nakai S, Akiba T, Kazama J, et al. Effects of serum calcium,phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan [J]. Ther Apher Dial,2008, 12(1): 49-54.
|
| 5 |
Kalantar-Zadeh K, Kuwae N, Regidor DL,et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients [J]. Kidney Int, 2006, 70(4):771-780.
|
| 6 |
Guideline Working Group, Japanese Society for Dialysis Therapy.Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients [J]. Ther Apher Dial, 2008, 12(6): 514-525.
|
| 7 |
Neven E, De Schutter TM, De Broe ME, et al. Cell biological and physicochemical aspects of arterial calcification [J]. Kidney Int. 2011, 79(11): 1166-1177.
|
| 8 |
Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis [J]. J Am Soc Nephrol, 2011, 22(2): 216-224.
|
| 9 |
Mejía N, Roman-García P, Miar AB, et al. Chronic kidney disease--mineral and bone disorder: a complex scenario [J].Nefrologia, 2011, 31(5): 514-519.
|
| 10 |
Maeda S, Sutliff RL, Qian J, et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility [J]. Endocrinology, 1999, 140(4): 1815-1825.
|
| 11 |
Luo XH, Liao EY, Su X, et al. Parathyroid hormone inhibits the expression of membrane-type matrix metalloproteinase-1 (MT1-MMP) in osteoblast-like MG-63 cells [J]. J Bone Miner Metab,2004, 22(1): 19-25.
|
| 12 |
Cheng SL, Shao JS, Halstead LR, et al. Activation of vascular smooth muscle parathyroid hormone receptor inhibits Wnt/betacatenin signaling and aortic fibrosis in diabetic arteriosclerosis [J].Circ Res, 2010, 107(2): 271-282.
|
| 13 |
闫铁昆, 林珊, 贾俊亚, 等. 尿毒症患者桡动脉钙化与骨密度及血清骨代谢指标的关系 [J]. 中华肾脏病杂志, 2012, 28(12):916-921.
|
| 14 |
London GM, Marchais SJ, Guérin AP, et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD[J]. J Am Soc Nephrol, 2008, 19(9): 1827-1835.
|
| 15 |
Elder G, Kumar S. Calciphylaxis associated with chronic kidney disease and low bone turnover: management with recombinant human PTH-(1-34) [J]. NDT Plus, 2008, 2(1): 97-99.
|
| 16 |
Jean G, Bresson E, Lorriaux C, et al. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients [J]. Nephron Clin Pract, 2012,120(3): c132-c138.
|
| 17 |
Rashid G, Bernheim J, Green J, et al. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways [J]. Am J Physiol Renal Physiol,2007, 292(4): F1215-1218.
|
| 18 |
Pickard BW, Hodsman AB, Fraher LJ, et al. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1 [J]. Endocrinology,2007, 148(5): 2282-2289.
|
| 19 |
闫铁昆, 林珊, 贾俊亚, 等. 尿毒症患者桡动脉盐皮质激素受体表达与血管钙化的关系 [J]. 中华肾脏病杂志, 2010, 26(3):181-186.
|
| 20 |
胡建明, 吴宏飞, 王笑云, 等. 肾性甲状旁腺功能亢进症甲状旁腺全切加前臂移植31例临床分析 [J]. 中华内科杂志, 2006,45(9): 714-716.
|
| 21 |
Jung S, Querfeld U, Müller D, et al. Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats [J]. J Hypertens, 2012, 30(11): 2182-2191.
|
| 22 |
Sebastian EM, Suva LJ, Friedman PA. Differential effects of intermittent PTH(1-34) and PTH(7-34) on bone microarchitecture and aortic calcification in experimental renal failure [J]. Bone,2008, 43(6): 1022-1030.
|
| 23 |
Naranda J, Ekart R, Pečovnik-Balon B. Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism [J]. J Int Med Res, 2011, 39(3):978-987.
|
| 24 |
London GM, Marchais SJ, Guérin AP, et al. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD[J]. J Am Soc Nephrol, 2008, 19(9):1827-1835.
|
| 25 |
De Schutter TM, Behets GJ, Jung S, et al. Restoration of bone mineralization by cinacalcet is associated with a significant reduction in calcitriol-induced vascular calcification in uremic rats [J]. Calcif Tissue Int, 2012, 91(5):307-315.
|
| 26 |
Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study:a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis[J]. Nephrol Dial Transplant, 2011, 26(4): 1327-1339.
|
| 27 |
Silverman SL, Nasser K. Teriparitide update[J]. Rheum Dis Clin North Am, 2011, 37(3): 471-477.
|
| 28 |
Miller PD, Schwartz EN, Chen P, et al. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment [J]. Osteoporos Int, 2007, 18(1): 59-68.
|